Effects of capsaicin on pharmacokinetics of pitavastatin in rats

References

• Al OZ, Ahmed YB, Habila MA, Ghafar AA. (2011). Determination of capsaicin and dihydrocapsaicin in Capsicum fruit samples using high performance liquid chromatography. Molecules 16:8919–29
   PubMed Web of Science ®Google Scholar
• Allred AJ, Bowen CJ, Park JW, et al. (2011). Eltrombopag increases plasma rosuvastatin exposure in healthy volunteers. Brit J Clin Pharmaco 72:321–9
   PubMed Web of Science ®Google Scholar
• Aoki T, Nishimura H, Nakagawa S, et al. (1997). Pharmacological profile of a novel synthetic inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. Arzneimittelforschung 47:904–9
   PubMed Web of Science ®Google Scholar
• Babbar S, Chanda S, Bley K. (2010). Inhibition and induction of human cytochrome P450 enzymes in vitro by capsaicin. Xenobiotica 40:807–16
   PubMed Web of Science ®Google Scholar
• Benet L. (2002). Changes in plasma protein binding have little clinical relevance. Clin Pharmacol Ther 71:115–21
   PubMed Web of Science ®Google Scholar
• Bley K, Boorman G, Mohammad B, et al. (2012). A comprehensive review of the carcinogenic and anticarcinogenic potential of capsaicin. Toxicol Pathol 40:847–73
   PubMed Web of Science ®Google Scholar
• Catapano AL. (2010). Pitavastatin – pharmacological profile from early phase studies. Atheroscler Suppl 11:3–7
   PubMed Web of Science ®Google Scholar
• Elsby R, Hilgendorf C, Fenner K. (2012). Understanding the critical disposition pathways of statins to assess drug-drug interaction risk during drug development: it's not just about OATP1B1. Clin Pharmacol Ther 92:584–98
   PubMed Web of Science ®Google Scholar
• Fujino H, Saito T, Tsunenari Y, et al. (2004). Metabolic properties of the acid and lactone forms of HMG-CoA reductase inhibitors. Xenobiotica 34:961–71
   PubMed Web of Science ®Google Scholar
• Han EH, Hwang YP, Kim HG, et al. (2011). CCAAT/enhancer-binding protein beta activation by capsaicin contributes to the regulation of CYP1A1 expression, mediated by the aryl hydrocarbon receptor. Br J Pharmacol 164:1600–13
   PubMed Web of Science ®Google Scholar
• Hernandez-Ortega M, Ortiz-Moreno A, Hernandez-Navarro MD, et al. (2012). Antioxidant, antinociceptive, and anti-inflammatory effects of carotenoids extracted from dried pepper (Capsicum annuum L.). J Biomed Biotechnol 2012:1–10
   PubMed Web of Science ®Google Scholar
• Hirano M, Maeda K, Matsushima S, et al. (2005). Involvement of BCRP (ABCG2) in the biliary excretion of pitavastatin. Mol Pharmacol 68:800–7
   PubMed Web of Science ®Google Scholar
• Hirano M, Maeda K, Shitara Y, Sugiyama Y. (2006). Drug–drug interaction between pitavastatin and various drugs via OATP1B1. Drug Metab Dispos 34:1229–36
   PubMed Web of Science ®Google Scholar
• Hui CK, Cheung BM, Lau GK. (2005). Pharmacokinetics of pitavastatin in subjects with Child-Pugh A and B cirrhosis. Br J Clin Pharmacol 59:291–7
   PubMed Web of Science ®Google Scholar
• Imatake K, Matsui T, Moriyama M. (2009). The effect and mechanism of action of capsaicin on gastric acid output. J Gastroenterol 44:396–404
   PubMed Web of Science ®Google Scholar
• Kato R, Higashitani A, Irie T, et al. (2012). Influence of capsaicin on fluctuation of digoxin pharmacokinetics in lipopolysaccharide-treated rats. Xenobiotica 42:798–807
   PubMed Web of Science ®Google Scholar
• Lopez-Carrillo L, Hernandez AM, Dubrow R. (1994). Chili pepper consumption and gastric cancer in Mexico: a case-control study. Am J Epidemiol 139:263–71
   PubMed Web of Science ®Google Scholar
• Monsereenusorn Y. (1983). Subchronic toxicity studies of capsaicin and capsicum in rats. Res Commun Chem Pathol Pharmacol 41:95–110
   PubMedGoogle Scholar
• Mukhtar RY, Reid J, Reckless JP. (2005). Pitavastatin. Int J Clin Pract 59:239–52
   PubMed Web of Science ®Google Scholar
• Prueksaritanont T, Chu X, Gibson C, et al. (2013). Drug–drug interaction studies: regulatory guidance and an industry perspective. AAPS J 15:629–45
   PubMed Web of Science ®Google Scholar
• Saito Y, Yamada N, Teramoto T, et al. (2002). A randomized, double-blind trial comparing the efficacy and safety of pitavastatin versus pravastatin in patients with primary hypercholesterolemia. Atherosclerosis 162:373–9
   PubMed Web of Science ®Google Scholar
• Schachter M. (2005). Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update. Fundam Clin Pharmacol 19:117–25
   PubMed Web of Science ®Google Scholar
• Sharma P, Butters CJ, Smith V, et al. (2012). Prediction of the in vivo OATP1B1-mediated drug-drug interaction potential of an investigational drug against a range of statins. Eur J Pharm Sci 47:244–55
   PubMed Web of Science ®Google Scholar
• Shitara Y, Sato H, Sugiyama Y. (2005). Evaluation of drug-drug interaction in the hepatobiliary and renal transport of drugs. Annu Rev Pharmacol Toxicol 45:689–723
   PubMed Web of Science ®Google Scholar
• Surh YJ, Lee SS. (1996). Capsaicin in hot chili pepper: carcinogen, co-carcinogen or anticarcinogen? Food Chem Toxicol 34:313–16
   PubMed Web of Science ®Google Scholar
• Takanohashi T, Isaka M, Ubukata K, et al. (2010). Studies of the toxicological potential of capsinoids, XIII: inhibitory effects of capsaicin and capsinoids on cytochrome P450 3A4 in human liver microsomes. Int J Toxicol 29:22S–6S
   PubMed Web of Science ®Google Scholar
• Wilkinson GR, Shand DG. (1975). Commentary: a physiological approach to hepatic drug clearance. Clin Pharmacol Ther 18:377–90
   PubMed Web of Science ®Google Scholar
• Williamson B, Soars AC, Owen A, et al. (2013). Dissecting the relative contribution of OATP1B1-mediated uptake of xenobiotics into human hepatocytes using siRNA. Xenobiotica 43:920–31
   PubMed Web of Science ®Google Scholar
• Zhai X, Lu Y. (2012). Food–drug interactions: effect of capsaicin on the pharmacokinetics of galantamine in rats. Xenobiotica 42:1151–5
   PubMed Web of Science ®Google Scholar
• Zhai XJ, Chen JG, Liu JM, et al. (2013a). Food-drug interactions: effect of capsaicin on the pharmacokinetics of simvastatin and its active metabolite in rats. Food Chem Toxicol 53:168–73
   PubMed Web of Science ®Google Scholar
• Zhai XJ, Shi F, Chen F, Lu YN. (2013b). Capsaicin pretreatment increased the bioavailability of cyclosporin in rats: involvement of P-glycoprotein and CYP 3A inhibition. Food Chem Toxicol 62:323–8
   PubMed Web of Science ®Google Scholar